Clinical Comparison of Three Different Chemotherapy Regimens Including Cisplain for Advanced Non-small Cell Lung Cancer

Objective To evaluate the short-time effects and toxic side-effects of EP, GP, NP regimens for patients with advanced Non-small Cell Lung Cancer (NSCLC). Methods The 157 cases of patients with advanced NSCLC were divided into three groups, given VP-16 plus DDP (EP) regimen or NVB plus DDP (NP) regimen or GEM plus DDP (GP) regimen respectively. There were 42 patients in group EP and 56 patients in group NP and 59 patients in group GP. On the research, the short-time effects and toxic side-effects were observ...